A pharmacogenomic approach validates AG-221 as an effective and on-target therapy in IDH2 mutant AML - PubMed (original) (raw)

. 2017 Jun;31(6):1466-1470.

doi: 10.1038/leu.2017.84. Epub 2017 Mar 10.

Affiliations

A pharmacogenomic approach validates AG-221 as an effective and on-target therapy in IDH2 mutant AML

L M Kats et al. Leukemia. 2017 Jun.

No abstract available

PubMed Disclaimer

References

    1. Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50 - PubMed
    1. Cancer Cell. 2010 Mar 16;17 (3):225-34 - PubMed
    1. Science. 2002 Oct 18;298(5593):601-4 - PubMed
    1. Best Pract Res Clin Haematol. 2015 Jun-Sep;28(2-3):112-5 - PubMed
    1. Nature. 2012 Feb 15;483(7390):484-8 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources